Yüklüyor......
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
INTRODUCTION: Continuous infusion (CI) of clotting factors as a replacement therapy for perioperative hemostatic protection has been performed for many years, including with factors VIII and IX and recombinant activated factor VII (rFVIIa). This approach provides steady factor levels without requiri...
Kaydedildi:
| Yayımlandı: | J Blood Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276614/ https://ncbi.nlm.nih.gov/pubmed/30568523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S184040 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|